The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis

Stanley B Cohen

doi:10.1016/j.rdc.2004.01.005

The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis

Rheumatic Disease Clinics of North America ◽

10.1016/j.rdc.2004.01.005 ◽

2004 ◽

Vol 30 (2) ◽

pp. 365-380 ◽

Cited By ~ 52

Author(s):

Stanley B Cohen

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

Interleukin-1 Receptor Antagonist Treatment in Rheumatoid Arthritis

Modern Therapeutics in Rheumatic Diseases ◽

10.1385/1-59259-239-2:109 ◽

2003 ◽

pp. 109-120 ◽

Cited By ~ 1

Author(s):

Barry Bresnihan

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores

Arthritis & Rheumatism ◽

10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p ◽

2000 ◽

Vol 43 (5) ◽

pp. 1001 ◽

Cited By ~ 252

Author(s):

Yebin Jiang ◽

Harry K. Genant ◽

Iain Watt ◽

Mark Cobby ◽

Barry Bresnihan ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Controlled Study ◽

Double Blind ◽

Interleukin 1 Receptor Antagonist ◽

Dose Ranging ◽

Radiologic Progression

Download Full-text

Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity

IUBMB Life ◽

10.1002/iub.1205 ◽

2013 ◽

pp. n/a-n/a

Author(s):

Menha Swellam ◽

Khadiga M. Abu Gabal ◽

Samar Samir Youssef

Keyword(s):

Rheumatoid Arthritis ◽

Gene Polymorphism ◽

Disease Activity ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist

Annals of the Rheumatic Diseases ◽

10.1136/ard.58.2008.i96 ◽

1999 ◽

Vol 58 (Supplement 1) ◽

pp. i96-i98 ◽

Cited By ~ 19

Author(s):

B. Bresnihan

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2010.141077 ◽

2011 ◽

Vol 70 (5) ◽

pp. 858-863 ◽

Cited By ~ 16

Author(s):

M. Corr ◽

D. L. Boyle ◽

L. M. Ronacher ◽

B. R. Lew ◽

L. G. van Baarsen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interferon Beta ◽

Interleukin 1 ◽

Beneficial Effects ◽

Interleukin 1 Receptor Antagonist

Download Full-text

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis

PLoS ONE ◽

10.1371/journal.pone.0153752 ◽

2016 ◽

Vol 11 (4) ◽

pp. e0153752 ◽

Cited By ~ 2

Author(s):

Endom Ismail ◽

Omimah Khaled Jaber Nofal ◽

Rajalingham Sakthiswary ◽

Syahrul Sazliyana Shaharir ◽

Radhika Sridharan

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Clinical Significance ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis

Clinical Rheumatology ◽

10.1007/s10067-017-3610-0 ◽

2017 ◽

Vol 36 (6) ◽

pp. 1247-1252 ◽

Cited By ~ 1

Author(s):

S. Ramírez-Pérez ◽

M. Salazar-Páramo ◽

S. Pineda-Monjarás ◽

U. De la Cruz-Mosso ◽

J. Hernández-Bello ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Tandem Repeat ◽

Interleukin 1 ◽

Variable Number ◽

Clinical Activity ◽

Vntr Polymorphism ◽

Interleukin 1 Receptor Antagonist

Download Full-text

Gene therapy for rheumatoid arthritis: Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators

Rheumatic Disease Clinics of North America ◽

10.1016/s0889-857x(03)00073-5 ◽

2002 ◽

Vol 28 (1) ◽

pp. 127-149 ◽

Cited By ~ 42

Author(s):

Fons A.J van de Loo ◽

Wim B van den Berg

Keyword(s):

Rheumatoid Arthritis ◽

Gene Therapy ◽

Animal Models ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 10 ◽

Interleukin 4 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

Reumatismo ◽

10.4081/reumatismo.2004.1s.74 ◽

2011 ◽

Vol 56 (1s) ◽

Author(s):

L. Riente

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text

The effects of treatment with interleukin‐1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/40.1.62 ◽

2001 ◽

Vol 40 (1) ◽

pp. 62-69 ◽

Cited By ~ 69

Author(s):

G. Cunnane ◽

A. Madigan ◽

E. Murphy ◽

O. FitzGerald ◽

B. Bresnihan

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Synovial Membrane ◽

Interleukin 1 ◽

Interleukin 1 Receptor Antagonist

Download Full-text